Massari, Francesco

Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study

Zanchetta, M. B., Boailchuk, J., Massari, F., Silveira, F., Bogado, C., & Zanchetta, J. R. (2018) · Osteoporosis International

Bone health and osteoporosis researchBone health and treatments

Cited by 119

Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials

Rizzo, A., Mollica, V., Santoni, M., Ricci, A. D., Rosellini, M., Marchetti, A., Montironi, R., Ardizzoni, A., & Massari, F. (2022) · European Urology Focus

Renal cell carcinoma treatmentCancer Immunotherapy and Biomarkers

Cited by 91

The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System

Raschi, E., Fusaroli, M., Massari, F., Mollica, V., Repaci, A., Ardizzoni, A., Poluzzi, E., Pagotto, U., & Di Dalmazi, G. (2022) · The Journal of Clinical Endocrinology & Metabolism

Pharmacovigilance and Adverse Drug ReactionsAdrenal Hormones and Disorders

Cited by 17